GIAPREZA

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug GIAPREZA contains one active pharmaceutical ingredient (API):

1 Angiotensin II UNII M089EFU921 - ANGIOTENSIN II

Angiotensin II raises blood pressure by vasoconstriction; increased aldosterone release via direct action of angiotensin II on the vessel wall is mediated by binding to the G-protein-coupled angiotensin II receptor type 1 on vascular smooth muscle cells which stimulates Ca2+/calmodulindependent phosphorylation of myosin and causes smooth muscle contraction. Read about Angiotensin II

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GIAPREZA Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR
GIAPREZA Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01CX09		C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CX Other cardiac stimulants
Discover more medicines within C01CX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1800694, 1800706, 1849271
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 142069
Country: FR	Base de données publique des médicaments	Identifier(s): 64441114
Country: IT	Agenzia del Farmaco	Identifier(s): 048208019, 048208021, 048208033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088389, 1088390, 1092290
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100425067
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69477001
Country: US	FDA, National Drug Code	Identifier(s): 68547-501